1013-17: ADHD Across the Lifespan: Research Update

4.58 (149 votes)

  • Registration Closed

1013-17: ADHD Across the Lifespan: Research Update

The purpose of this session is to increase awareness of prevalence of ADHD persisting into adulthood and underlying neurobiology.

Presenter: Philip Shaw, MD, PhD

Disclosures: Discussion of off-label uses (using products for a purpose other than that for which it was approved by the Food and Drug Administration, or FDA) will occur in this presentation.

Session Length:
1 hour 25 minutes

Target Audience: RN, APRN 

Session Objectives:

Upon completion of this presentation, the participant will be able to:

  1. Describe the prevalence of ADHD persisting into adulthood.
  2. Discuss the biology related to roles of persistence of ADHD.
  3. Apply principles of neurobiology to remission in ADHD.

Keywords: ADHD, Practice, Pharmacology

Continuing Nursing Education
1.5 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the post test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Originally Presented

APNA 15th Annual Clinical Psychopharmacology Institute
Hyatt Regency Baltimore on the Inner Harbor
Sunday, June 11, 2017
9:45am - 11:15am

The contact hours for this session expire: July 1, 2019

Components visible upon registration.